Another positive piece of newsflow outta ARV, @pustayo. Gotta...

Another positive piece of newsflow outta ARV, @pustayo. Gotta say, for a small cap, I like their activity and consistent communications (ol' David Lenigas is a superb marketer). Gotta think this will move soon.

(Jim, apologies for dropping likes in your office – bad habit, will cease).

Outside the mining space, BOT at these levels starting to look interesting. Raised around $0.052 a couple of months back. Like a lot of biotechs, however, the roll of the dice is whether their trials turn up positive results that can be commercialised (FDA approved etc).